‌

US Patent 8822475 Compounds and method for treatment of cancer

Patent 8822475 was granted and assigned to Critical Outcome Technologies, Inc. on September, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

‌

Critical Outcome Technologies, Inc.

Current Assignee

‌

Critical Outcome Technologies, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8822475

Patent Inventor Names

Martyn Brown0

Wayne R. Danter0

Franck LePifre0

Date of Patent

September 2, 2014

Patent Application Number

13770749

Date Filed

February 19, 2013

Patent Primary Examiner

‌

Kamal Saeed

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8822475 Compounds and method for treatment of cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API